Stephan Grupp

Stephan Grupp, MD, PhD is the Novotny Professor of Pediatrics at the Univesity of Pennsylvania Perelman School of Medicine and the Section Chief of Cellular Therapy and Transplant, Director of the Cancer Immunotherapy Program, and Medical Director of the Cell and Gene Therapy Lab at the Children’s Hospital of Philadelphia. Over 200 scientific publications have been generated by Dr. Grupp’s research, and he has received numerous achievement and impact awards for his contributions to the cell therapy and oncology fields, including election to the National Academy of Medicine. Dr. Grupp has extensive experience with cell therapy clinical development and commercialization, having led all of the pediatric/young adult ALL trials leading to the first FDA (and now international) approval of a CAR T therapy. He received his MD and PhD from the University of Cincinnati College of Medicine and completed fellowship training at Harvard Medical School, Boston Children’s Hospital, Dana Farber Cancer Institute and Brigham and Women’s Hospital.